Latest Breaking News On - Haffkine bio pharmaceutical corporation limited - Page 1 : comparemela.com

Stock Market Live Updates: Market outlook: Positive start expected amidst interim Budget and earnings focus

Audit at HBPCL: From fund transfer to London to losses in crores, CAG raises questions on Haffkine's functioning | Mumbai News

The audit observed that ‘not complying with the directions of the Supreme Court, the company incurred the business loss of Rs 50.69 crore.’

Audit at HBPCL: From fund transfer to London to losses in crores, CAG raises questions on Haffkine\u2019s functioning

The Maharashtra government is currently probing a series of irregularities at Haffkine Bio Pharmaceutical Corporation Limited after the CAG\u2019s inspection report in July 2023 made observations which range from transfer of funds to London-based bank account to losses to the company amounting to over Rs 50 crore on account of not following the Supreme Court order. The report stated that the HBPCL suffered losses worth Rs 50.69 crore in

Global Anti-Venom Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

/PRNewswire/ The "Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to.

Global Anti-Venom Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

/PRNewswire/ The "Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to.